The Federal Drug Administration recently approved a generic equivalent for the brand-name drug Lipitor. The generic, atorvastatin, will cost less than Lipitor, and Lipitor will move to the third prescription tier (non-preferred brand-name drugs), which will change the co-pay for Lipitor prescriptions. For additional information, please visit the related Change in LIPITOR letter (pdf).